BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21899859)

  • 1. Carotid body remodelling in l-NAME-induced hypertension in the rat.
    Felix AS; Rocha VN; Nascimento AL; de Carvalho JJ
    J Comp Pathol; 2012 May; 146(4):348-56. PubMed ID: 21899859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.
    Neto-Ferreira R; Novaes Rocha V; da Silva Torres T; Mandarim-de-Lacerda CA; de Carvalho JJ
    Exp Toxicol Pathol; 2011 Jul; 63(5):473-8. PubMed ID: 20537513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
    Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of prior physical conditioning on relaxing response of corpus cavernosum from rats made hypertensive by nitric oxide inhibition.
    Claudino MA; Priviero FB; Camargo EA; Teixeira CE; De Nucci G; Antunes E; Zanesco A
    Int J Impot Res; 2007; 19(2):189-95. PubMed ID: 16915305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
    BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats.
    Kang DG; Sohn EJ; Lee YM; Lee AS; Han JH; Kim TY; Lee HS
    J Ethnopharmacol; 2004 Mar; 91(1):51-6. PubMed ID: 15036467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor attenuates Nomega-nitro-L-arginine methyl ester-induced preeclampsia-like manifestations in rats.
    Chen D; Wang H; Huang H; Dong M
    Clin Exp Hypertens; 2008 Oct; 30(7):606-15. PubMed ID: 18855264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased total volume and dopamine β-hydroxylase immunoreactivity of carotid body in spontaneously hypertensive rats.
    Kato K; Wakai J; Matsuda H; Kusakabe T; Yamamoto Y
    Auton Neurosci; 2012 Jul; 169(1):49-55. PubMed ID: 22546625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
    Hsieh NK; Wang JY; Liu JC; Wang SD; Chen HI
    Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):212-8. PubMed ID: 15053816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in L-NAME induced hypertensive rats.
    Saravanakumar M; Raja B
    Eur J Pharmacol; 2011 Dec; 671(1-3):87-94. PubMed ID: 21937012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical conditioning modulates rat cardiac vascular endothelial growth factor gene expression in nitric oxide-deficient hypertension.
    Husain K
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1169-74. PubMed ID: 15249212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
    Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aluminum on the blood-brain barrier permeability during nitric oxide-blockade-induced chronic hypertension in rats.
    Kaya M; Kalayci R; Arican N; Küçük M; Elmas I
    Biol Trace Elem Res; 2003 Jun; 92(3):221-30. PubMed ID: 12794274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats.
    Benova M; Herichova I; Stebelova K; Paulis L; Krajcirovicova K; Simko F; Zeman M
    Hypertens Res; 2009 Apr; 32(4):242-7. PubMed ID: 19262491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
    Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
    Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.